Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Oncodesign has formed a new strategic alliance with HitGen, a Chinese biotech company.
read more
Synairgen has announce that recruitment of 100 hospitalised patients in its clinical trial of SNG001 in COVID-19 patients has now been completed.
read more
Pelican BioThermal announced the opening of a new network station and drop point in Incheon, South Korea as the country eyes pharmaceutical development as a primary driver of economic growth.
read more
Jonas Skjødt Møller is Rosholm’s successor as Chief Executive Officer effective July 1, 2020.
read more
The NIIMBL announces that they have received $8.9 million from the U.S. Department of Commerce's NIST.
read more
NewAge Industries has closed a deal to buy two building units at a location within seven miles of its southeastern Pennsylvania headquarters.
read more
SeraNovo has signed a second License Agreement with Carna Biosciences.
read more
Oncodesign and HitGen announced the start of a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities.
read more
Boehringer Ingelheim and Eli Lilly announced a research collaboration with DCRI for the prevention of Chronic heart failure and mortality after an acute Myocardial Infarction.
read more
Bio-Techne and Leica Biosystems have announced the European launch of the CE-IVD marked RNAscope™ In Situ Hybridization Detection Kit for automation on the BOND-III platform.
read more
Chi-Med and BeiGene have entered into a collaboration agreement to evaluate two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for solid tumor cancers.
read more
ArcherDX announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase 3 clinical trials for AstraZeneca's targeted immuno-oncology therapeutics.
read more
Catalent announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing agreement with Humanigen for the fill finish supply of lenzilumab currently being studied in a trial for COVID-19.
read more
ADMA Biologics has commenced the collection of convalescent plasma through its wholly-owned subsidiary from individuals who have recovered from COVID-19.
read more